May 2022 Arthritis News Roundup

The Arthritis Foundation is your trusted source for arthritis-related news and COVID updates that affect people with arthritis. Here’s a wrap-up of the headlines from this past month. 

Want arthritis news daily? You’re in luck. Coming this summer, important news that affects you will be found online — so you won’t have to wait for a monthly email to learn about the latest advancements in treatments, the newest study findings, important COVID updates and more. Stay tuned for our launch announcement coming soon.

The Latest in COVID-19 News & Arthritis

FDA Approves COVID Booster for Ages 5-11

FDA修订了辉瑞- biontech COVID-19疫苗的紧急使用授权,授权5至11岁的个人使用单一加强剂。Learn more.

Know Your COVID-19 Community Level

The CDC recently unveiled COVID-19 Community Levels, a tool to help communities decide what prevention steps to take based on the latest data. Levels can be low, medium or high and are determined by looking at hospital beds being used, hospital admissions and the total number of new COVID-19 cases in an area.Check your community level.

Quarantine & Isolation Calculator FAQ

获取最新的CDC工具,以帮助确定隔离、隔离或采取其他步骤所需的时间,以防止COVID-19传播。Try the tool.

获取针对关节炎患者的最新COVID-19指南。Visit ourCare & Connect pageto find the latest coronavirus information.

In Other Arthritis News

Healthy-Appearing Lupus Skin Predisposed to Flares, Rashes

In patients with lupus, a new study finds that the normal-appearing skin of lupus patients contains the same inflammatory signals that are detected when the skin develops a rash, sometimes at even higher levels.Read more.

Rising Incidence of Lupus

A new study has found the incidence and prevalence of systemic lupus erythematosus are increasing.Learn more about the study findings.

患有狼疮等慢性疾病会对你的情绪健康造成损害。学习如何建立一个更好的自我形象,开始对自己的身体感觉良好。Read more.

Infection Risks Similar With TNFi and cDMARDs Plus MTX

According to study results published inSeminars in Arthritis & Rheumatology,在伴有甲氨蝶呤治疗的类风湿关节炎(RA)患者中,来氟米特和肿瘤坏死因子抑制剂(TNFis)与他克莫司和TNFis之间发生严重感染的风险没有差异。Learn more.

Healthy Lifestyle Modifications May Lower Risk of Genetically Induced Gout

While genetics are linked to gout diagnosis and lifestyle factors are related to risk, a healthy lifestyle was associated with a lower risk of gout, mitigating risk related to genetic factors by almost a third, according to a study published inBMC Medicine.Find out more about this study.

学习与痛风的健康生活方式的做和不要。找出哪些食物是最好的,哪些应该避免来预防耀斑。Learn more.

Less Frequent Methotrexate Monitoring May Be Safe

Reducing the frequency of routine blood monitoring for methotrexate in patients with rheumatoid arthritis during the COVID-19 pandemic was associated with no adverse outcomes for patients.Read more.

Methotrexate is one of the most commonly prescribed arthritis medicines.Learn what to expect if you take it.

世界杯2022赛程时间表

This Arthritis Awareness Month, look out for Arthritis Foundation billboards in select cities across the U.S. as we work to raise awareness about arthritis and the nearly 60 million people it affects.Journey with usto find the resources and support you need to thrive.

The Arthritis Foundation is your trusted source for arthritis-related news and COVID updates that affect people with arthritis. Here’s a wrap-up of the headlines from this past month. 

The Latest in COVID-19 News & Arthritis

White House Says COVID Treatment Paxlovid Going Nationwide

As cases rise, the White House is expanding access and use of Paxlovid, a medication made by Pfizer used to treat people 12 and older who have contracted COVID-19 and are at high risk of severe disease. Paxlovid has been found to reduce the risk of COVID-related hospitalization by 90%.Learn more.

Fauci Clarifies ‘Out of the Pandemic Phase’ Comment

As the nation’s top infectious disease expert, what Anthony Fauci, MD, says carries considerable weight, and his statement that the U.S. was “out of the pandemic phase” made national headlines. But a day later, Fauci clarified his comments — saying the country is not out of the pandemic, but “out of the full-blown explosive pandemic phase.”Read more.

Know Your COVID-19 Community Level

The CDC recently unveiled COVID-19 Community Levels, a tool to help communities decide what prevention steps to take based on the latest data. Levels can be low, medium or high and are determined by looking at hospital beds being used, hospital admissions and the total number of new COVID-19 cases in an area.Check your Community Level.

Quarantine & Isolation Calculator FAQ

获取最新的CDC工具,以帮助确定隔离、隔离或采取其他步骤所需的时间,以防止COVID-19传播。Try the tool.

获取针对关节炎患者的最新COVID-19指南。Visit ourCare & Connect pageto find the latest coronavirus information.

In Other Arthritis News

This Arthritis Awareness Month, we journey together.Find the resources and support你需要茁壮成长。

Mixed Feelings After Joint Replacement

While most osteoarthritis patients welcome the pain relief that comes with total knee replacement, some also experience psychological impacts that aren’t so pleasant.阅读这些病人的经历。

Is it time for joint replacement? Tune in to our expert Q&A to hear an orthopedic surgeon share advice on when to get joint replacement surgery.Watch now.

Insights on Overall & Cardiovascular-Specific Mortality in AS & PsA

一项新的分析结果显示,患有强直性脊柱炎的人——而不是银屑病关节炎的人——面临着总体死亡率显著增加的风险。然而,与普通人群相比,这两种疾病的心血管死亡率更高。Read the findings.

One Benefit We Don’t See From RA Biologics

Disability claims in the United States related to rheumatoid arthritis were just as common in 2015 as in 1999, a government researcher found, against expectations that the advent of biologic therapy would have led to a steady decrease.Read more.

Opioid Distributors Reach Settlement With Washington State

华盛顿与药品分销商McKesson Corp、AmerisourceBergen Corp和Cardinal Health Inc.达成了5.18亿美元的和解协议,结束了围绕这些公司涉嫌助长该州阿片类药物泛滥的长达数月的审判。Learn moreabout the settlement.

Benefits of reducing or stopping opioids outweigh the downsides.Click hereto get expert advice for stopping opioids.

FDA Approves New Drug for Adults With Ankylosing Spondylitis

FDA已批准每日一次口服厄帕达替尼(Rinvoq, AbbVie)用于治疗成人活动性强直性脊柱炎。FDA的批准是基于最近两项试验的有效性和安全性数据,这些试验发现upadacitinib在成年AS患者中显示出快速而有意义的疾病控制。Read moreabout the approval.

Get the facts about treating ankylosing spondylitis.Visit our AS treatment pagefor more information.

RAPID3 Questionnaire May Reduce Outpatient Visits in Patients With RA

The Routine Assessment of Patient Index Data 3 (RAPID3) was shown to have 92% accuracy in identifying low disease activity in patients with rheumatoid arthritis (RA), thus reducing 28% of on-site evaluations, according to a new study.Learn more.

Celiac Disease More Prevalent in Patients With Juvenile Idiopathic Arthritis

According to a study published inPediatric Rheumatology, ahigher percentage of celiac disease was reported in a large juvenile idiopathic arthritis cohort in Italy, which supports the need for screening in this patient population, especially for those with a family history of autoimmunity.Read more.

麸质和关节炎之间有联系吗?如果你有乳糜泻或麸质敏感,改变你的饮食可能有助于缓解关节炎症状。Learn why.

March 2022 Arthritis News Roundup

The Arthritis Foundation is your trusted source for arthritis-related news and COVID updates that affect people with arthritis.这里是 过去一个月 头条新闻的总结。

The Latest in COVID-19 News & Arthritis

Know Your COVID-19 Community Level

The CDC recently unveiled COVID-19 Community Levels, a tool to help communities decide what prevention steps to take based on the latest data. Levels can be low, medium or high and are determined by looking at hospital beds being used, hospital admissions and the total number of new COVID-19 cases in an area.Check your Community Level.

Omicron Leads to More Children Under 5 Hospitalized

Young children in the United States were hospitalizedat much higher rates last winter as omicron became the dominant variant, according to a疾控中心发布的新报告。Read more.

COVID-19 Vaccines Effective in Young Patients With Rheumatic Diseases

A two-dose regimen of COVID-19 mRNA vaccines elicited a robust humoral neutralization response in almost all adolescents and young adults with childhood-onset rheumatic diseases in a new study from Singapore.Read about the study.

CDC Outlines Treatment Options for Coronavirus Patients

Guidance from the CDC now explains best practices for health care professionals treating COVID-19 patients.Learn more about these guidelines.

获取针对关节炎患者的最新COVID-19指南。Visit ourCare & Connect pageto find the latest coronavirus information.

In Other Arthritis News

Sleep Apnea Linked to Joint Pain in Postmenopausal Women

Sleep apnea may lead to increased joint pain in postmenopausal women, according to a study published online.阅读学习。

关节炎会影响你的睡眠质量吗?Get expert sleep tips所以你可以休息得更健康,即使是在疼痛发作的时候。

RA Patients Impacted by Weight Changes

According to study results published inArthritis Care and Research, weight fluctuations could predict elevated cardiovascular risks in people with RA — particularly among thinner patients, who can be overlooked on the issue.Learn more.

Predicting Whether AS Patients Will Respond to Anti-TNFs

研究人员在一项建模研究中报告称,仅根据一项标准实验室测试和两项疾病活动度指标,对强直性脊柱炎患者使用TNF抑制剂治疗是否会显著改善的预测具有中等到较高的准确性。Read more about the study.

Steroid Injections as Safe as HA Shots for Knee OA

Corticosteroid injections are just as safe as hyaluronic acid injections in people with OA of the knee, study findings show.Learn more.

Learn more about steroid injections.Watch an expert Q&A这涵盖了关于这种治疗的最常见问题。

Knee Replacements in Patients Over 80

According toone study presented at the 2022 Annual Meeting of theAmerican Academy of Orthopaedic Surgeons, total knee arthroplasty in patients over 80 years old have lower levels of implant-related complications, but higher readmission rates, medical complications and length of stays.Read more.

Updated Perioperative Guidance on Antirheumatics

The American College of Rheumatology and the American Association of Hip and Knee Surgeons have released updated guidelines regarding whether to withhold drugs such as biologics and immunosuppressives for patients with inflammatory rheumatic disease who are scheduled to undergo elective total hip or knee replacement surgery.Learn more.

Disease-modifying antirheumatic drugs (DMARDs) stop or slow the disease process in inflammatory forms of arthritis.了解更多关于这类药物的信息。

Debate on Definition of Flare in Axial Spondyloarthritis

在实践中,如何最好地定义轴性脊椎关节炎耀斑仍然是一些争论的主题,这在第12届国际脊椎关节炎大会上的一个抽象报告之后的讨论中得到了证明。Read more.

Choosing Initial PsA Treatment

For patients withpsoriatic arthritiswhose condition doesn’t respond adequately tomethotrexate, the addition of the TNF inhibitoradalimumab根据一项4期开放标签研究的结果,增加达到最低疾病活动度的可能性。Learn more.

One-Third of PsA Patients Could Have Metabolic Syndrome

代谢综合征的患病率因其定义而异,但在一项724人的队列研究中,约30%的银屑病关节炎患者符合标准,在多项研究中约23%至63%的患者符合标准,来自西班牙的研究人员报告说。Read more.

Do you have questions about PsA treatments?Learn more关于专家推荐的各种银屑病关节炎治疗方案。

Trial Findings Question Need for Prehabilitation Before Total Knee Replacement

In this randomized clinical trial of 262 participants, multidisciplinary prehabilitation before total knee replacement for knee osteoarthritis did not improve short-term functional independence or reduce midterm activity limitations after surgery.Learn more.

February 2022 Monthly News Roundup

The Arthritis Foundation is your trusted source for arthritis-related news and COVID updates that affect people with arthritis.这里是 过去一个月 头条新闻的总结。

The Latest in COVID-19 News & Arthritis

Updated Guidance for Vaccination in Rheumatology Patients

As rheumatologists contend with vaccine hesitancy among certain subsets of patients, the American College of Rheumatology has released updated clinical guidelines on COVID-19 vaccination for patients with rheumatic and musculoskeletal diseases, including new recommendations on supplemental and booster doses.Read more.

通过访问关节炎基金会的关爱与联系门户网站,获取关于COVID-19的最新信息和新闻。

FDA Delays Action on Pfizer Vaccine for Kids Under 5

美国食品药品监督管理局表示,在获得三剂疫苗效果的数据之前,将推迟决定是否批准在低龄儿童中使用辉瑞公司的疫苗。Learn more.

FDA Considers Second COVID-19 Booster Shot

The FDA has begun reviewing data to potentially authorize a fourth dose of the Pfizer and Moderna COVID-19 vaccines for the fall. The authorization would depend on ongoing studies, which must show that a fourth dose would increase waning immunity and reduce the risk of severe disease.Read the story.

CDC Urges Extra Precautions for PeopleWith特定的医疗条件

美国疾病控制与预防中心(CDC)最近更新了针对某些疾病和免疫功能低下人群的指南。Get the latest suggestions from the CDC.

FDAOkaysNew Monoclonal Antibody Effective Against Omicron

The FDA authorized Eli Lilly’s COVID-19 antibody drug for people aged 12 and older at risk of severe illness, adding a tool that has been found to work against the highly contagious Omicron variant.Learn more about the treatment.

COVID-19 Vaccines Safe, Effective in Rheumatic Diseases

The European Alliance of Associations for Rheumatology Coronavirus Vaccine registry has shown that vaccination against SARS-CoV-2 provides people with inflammatory or noninflammatory rheumatic and musculoskeletal disease similar levels of protection with a similar adverse event profile as the general public.Read more about the findings.

为关节炎患者获取COVID-19最常见问题的答案。

In Other Arthritis News

CDC Releases Updated Draft Guidance on Opioid Prescribing

美国疾病控制与预防中心(CDC)发布了最新的关于处方阿片类药物治疗疼痛的临床实践指南草案,并在进一步推进之前征求公众意见。Read the new draft update.

今天下载Vim应用程序,你会发现大量的资源和支持,你需要它们来管理你的痛苦。

Dietary Recommendations for Inflammatory Rheumatic Diseases

Jérémie Sellam, MD, PhD, from Saint-Antoine Hospital in Paris, summarizes the key points of the first set of dietary recommendations of the French Society for Rheumatology.
Read the recommendations.

Find out how the Ultimate Arthritis Diet could help your joints feel better.

Multiple Sleep Problems May Boost Heart Disease Risk by More Than 140%

New research shows that having more than one sleep problem increased an individual’s risk of heart disease by up to 141% in a retrospective analysis.Learn more about this study.

Physical Activity Impacts Quality of Life for People With Inflammatory Arthritis

According to a lit review published recently inArthritis Care & Research, p运动可以改善类风湿关节炎(RA)、脊椎关节炎(SpA)和银屑病关节炎(PsA)患者的生活质量和自我报告功能。Read the review.

Get active without hurting your joints. Try the YES (Your Exercise Solution) tool to find movements based on your specific needs and ability level — with modifications developed and approved by physical therapists.Try YES today.

January 2022 Arthritis News Roundup

The Arthritis Foundation is your trusted source for arthritis-related news and COVID updates that affect people with arthritis.这里是 过去一个月 头条新闻的总结。

The Latest in COVID-19 News & Arthritis

Arthritis Drugs May Reduce COVID-19 Vaccine Effectiveness

According to limited research, evidence suggests that disease-modifying drugs used for arthritis may reduce the response of the mRNA COVID-19 vaccines from Pfizer and Moderna.Read more.

Booster Shots Strongly Protect Against Severe Disease From Omicron Variant

根据三份使用真实数据的报告,疫苗增强剂在美国提供了对欧微米变体严重疾病的强大保护,这些报告显示,接种疫苗可以有效地让接种疫苗的人远离医院。Learn more.

欧米克隆热潮在美国达到顶峰了吗?

一些专家认为,美国的COVID-19病例终于下降了,这是一个可喜的消息,此前近两个月,由于具有高度传染性的欧微米变体,病例数飙升。Find out more.

U.S. Starts Shipping Free COVID-19 Tests Amid Omicron

The U.S. Postal Service has begun shipping free at-home rapid COVID-19 tests after millions of orders were placed through a new federal website launched last week.Learn more.

Immune Dysfunction Linked to Risk of Breakthrough COVID-19 Infection

Although vaccines reduce the overall risk for COVID-19, regardless of immune status, patients with immune dysfunction are at a substantial risk for breakthrough infection versus those without, according to data.Read more.

Association Between Three Doses of COVID-19 Vaccine and Symptomatic Infection

Findings suggest that vaccination with three doses of mRNA COVID-19 vaccine, compared with being unvaccinated and with receipt of 2 doses, was associated with protection against both the omicron and delta variants.Read the report.

Patients Taking Rituximab Show Negligible Antibody Response to COVID-19 Vaccines

anca相关血管炎(AAV)患者在标准的两剂辉瑞生物技术疫苗方案后,对delta变体没有产生持久的抗体反应——对于那些使用利妥昔单抗(利妥昔an)作为维持治疗的患者,即使是第三剂也没有多大帮助。Learn more.

In Other Arthritis News

Antidepressant for Osteoarthritis Doesn’t Meet Expectations

此前的研究表明,抗抑郁药物度洛西汀(欣百达)有助于缓解OA患者的疼痛,因此建议将其作为临床工具包的一部分。但现在,一项新的试验对这种方法在现实世界中的益处提出了质疑。阅读学习。

Ankylosing Spondylitis Patients Don’t Always Fit the Mold

Even for a stereotypical patient, ankylosing spondylitis can take years to get diagnosed. If, like Christi Taylor-Gentry, you’re seen as an anomaly, the delay can be even more extreme.Read her story.

A Statistician Explores Painfully Weak Evidence for Collagen

“我的膝盖还没有严重到需要手术的程度,但我已经尝试了几乎所有其他方法。类固醇注射起到了缓解作用,但只能维持一周。当我虔诚地做运动时,物理疗法是有效的,但最近几个月我放弃了。所以,我想我可以试试胶原蛋白补充剂。”Learn more.

FDA Approves Risankizumab (Skyrizi) for Psoriatic Arthritis

The FDA approved risankizumab-rzaa (Skyrizi) for a second indication — treating adults with active psoriatic arthritis — making it the second anti-interleukin 23 monoclonal antibody available to treat PsA.Read the announcement.

Hip OA Burden Increasing in Almost All Countries

The burden of hip osteoarthritis has increased globally in the past 30 years, with incidence and disability-adjusted life years rising in nearly all countries, according to data published inArthritis Research & Therapy.Learn more.

Machine Learning IDs Predictors of Treatment Response in RA

Machine learning, integrating clinical and genomic data, can be used to predict methotrexate treatment response in early rheumatoid arthritis, according to a study published inArthritis Care & Research.Read the study.

University of Michigan Survey Seeks Input From Arthritis Patients Using Cannabis Products To Manage Pain

Do you use CBD or other medical cannabis products to manage arthritis pain? Share your experience with researchers.Take the survey.

December 2021 Arthritis News Roundup

The Arthritis Foundation is your trusted source for arthritis-related news and COVID updates that affect people with arthritis.这里是 过去一个月 头条新闻的总结。

The Latest in COVID-19 News & Arthritis

Omicron Surge Brings Highest Rate of Coronavirus Cases

随着高传染性欧微米变异病毒在全国继续激增,美国报告了自大流行开始以来新冠病毒平均7天感染人数的最高水平。Read more.

COVID Antiviral Drugs Are Here, Remain Scarce

Pfizer’s Paxlovid and Merck’s molnupiravir are both oral antiviral pills that can be taken at home to keep patients out of the hospital. They’re meant to be taken within the first few days of having COVID-19, and they reduce the risk of hospitalization and death by up to 88% for Paxlovid and 30% for molnupiravir. Supply is tight, and the rollout varies from state to state.Learn more.

CDC Recommends Pfizer, Moderna Vaccines Over J&J’s

The Centers for Disease Control and Prevention changed its recommendations for Covid-19 vaccines to make clear that shots made by Moderna and Pfizer/BioNTech are preferred over Johnson & Johnson’s vaccine.为什么学习。

COVID Vaccine Booster Recommended for Teens

Health officials authorized booster shots for 16- and 17-year-olds in response to an increase in COVID-19 cases, along with concerns about upcoming winter months.Read more.

FDA Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boosters

The Food and Drug Administration is planning to broaden eligibility for coronavirus vaccine booster shots, allowing 12- to 15-year-olds to receive third doses of Pfizer-BioNTech’s vaccine.Learn more.

In Other Arthritis News

FDA Adds Strict Safety Warnings on Arthritis Drugs

The FDA has added its strictest warning to the labels of drugs from Pfizer, Eli Lilly and AbbVie belonging to a class of anti-inflammatory treatments called JAK inhibitors, citing risk of serious health issues and death in patients 50 and over.Read more.

First JAK Inhibitor OK’d for Ankylosing Spondylitis

The FDA approved tofacitinib (Xeljanz, Xeljanz XR) for treating active ankylosing spondylitis in adults. Tofacitinib is the first JAK inhibitor approved for ankylosing spondylitis.Learn more.

Upadacitinib (Rinvoq) Gains Psoriatic Arthritis as Second FDA-Approved Indication

FDA已经批准了一种15 mg的upadacitinib缓释片(Rinvoq),用于对一种或多种抗肿瘤坏死因子药物反应不充分或不耐受的成人银屑病关节炎患者。此次批准是fda对选择性JAK抑制剂upadacitinib给予的第二个适应症,该药物此前于2019年获批用于类风湿性关节炎(RA)。Find out more.

AbbVie Updates Upadacitinib Prescription Guidelines Amidst Safety Concerns

AbbVie recently announced an amendment to its prescribing Information for upadacitinib. The drug, a selective JAK inhibitor, now states that it is intended for adults with moderate-to-severe rheumatoid arthritis who have had inadequate response or intolerance to at least one TNF blocker.Read more.

Mayo Clinic Researchers Use AI, Biomarkers to Personalize RA Treatment

Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence and pharmacogenomics to predict how patients will respond to treatments, and to personalize care.Learn more.

November 2021 Arthritis News Roundup

The Arthritis Foundation is your trusted source for arthritis-related news and COVID updates that affect people with arthritis.这里是 过去一个月 头条新闻的总结。

American College of Rheumatology Research Highlights

The 2021 American College of Rheumatology (ACR) Convergence conference was recently held, gathering researchers, clinicians and patients alike for a week of knowledge sharing to advance treatments, understanding and approaches to managing various rheumatic diseases.Read the highlights.

Listento the Live Yes! With Arthritis podcast episode showcasing all the exciting news from the 2021 ACR Convergence conference.

The Latest in COVID-19 News & Arthritis

COVID Vaccine Booster Approved for All Adults

卫生官员授权为所有美国成年人注射加强疫苗,以应对COVID-19病例的增加,以及对即将到来的假期和冬季的担忧。Learn more关于COVID疫苗助推器。

Mask-Wearing Cuts New COVID-19 Cases by Half

When people wear face masks to reduce the spread of the coronavirus, the number of new COVID-19 infections drops by 53%, according to anew study发表在《英国医学杂志》上Read moreabout this study.

Scientists Race to Find Out if Vaccines Stop Omicron

在人们对新冠病毒再次在全球爆发的担忧中,科学家们正在争相收集关于这种新的omicron变体的数据、它的能力,以及——或许最重要的——目前的疫苗将如何有效地预防它。Read moreabout the omicron variant.

In Other Arthritis News

Serious Infection Hospitalizations Have Declined in Patients With PsA

The rate of U.S. hospitalizations for three types of serious infections in patients with psoriatic arthritis (PsA) appears to have declined from 2012 to 2017.Learn more关于这些发现。

Diagnosed with psoriatic arthritis?Check out our PsA portal找出你需要知道的来控制。

类风湿性关节炎患者长期使用糖皮质激素与心血管风险增加有关

Each month of glucocorticoid use in middle-aged patients with rheumatoid arthritis increases their odds of a major adverse cardiac event by 14%, independent of their baseline cardiovascular risk, according to a Veterans Administration study.Read more.

Allopurinol Proves Noninferior to Febuxostat for Gout Relief

Allopurinol may finally start to get the respect that many rheumatologists feel it deserves as a first-line, urate-lowering treatment for gout, following results of a randomized trial showing that it was noninferior to febuxostat both in the overall trial population and in patients with stage 3 chronic kidney disease.Learn moreabout this study.

Find out how to live well with gout.View our gout webinar, led by renowned experts,

获取有关病因、症状、缓解和伴随条件的信息。

Vitamin D and Omega-3 Supplements Reduce Autoimmune Disease Risk

Among nearly 26,000 adults enrolled in a randomized trial, five years of vitamin D supplementation was associated with a 22% reduction in risk for confirmed autoimmune diseases, and five years of omega-3 fatty acid supplementation was associated with an 18% reduction in confirmed and probable incident autoimmune diseases.Read more关于这些发现。

Meet Olivia Kwan: One of Our Newest Foundation Sponsored Fellows!

Right now, access to care is not always guaranteed for arthritis patients, and the problem is even worse for children living with juvenile arthritis. A child with arthritis currently travels an average of 57 miles to be seen by a pediatric rheumatologist. The Arthritis Foundation has been working to help close the gap on the nation’s rheumatologist shortage through ourfellowship initiative. In 2018 we announcedfive fellowship awards; one of those grants was offered to the Riley Hospital for Children at Indiana University Health, which recently announced their fellowship has been awarded to Dr. Olivia Kwan.

Continue readingMeet Olivia Kwan: One of Our Newest Foundation Sponsored Fellows!

Survive & Thrive: Together in Isolation

It’s game on for Rob Gronkowski and Matt Iseman on the Live Yes! With Arthritis Podcast.

This was not your typical discussion about chronic pain and arthritis. There was laughing. There were singing and dancing. There was even juggling. It was just what we needed to cut through the isolation of the new coronavirus world. Former pro football player Rob Gronkowski – known by fans as “Gronk” – teamed up with Matt Iseman, host of美国的忍者武士and a longtime friend of the Arthritis Foundation who has rheumatoid arthritis, to share their stories and some laughs on the Live Yes! With Arthritis Podcast. Together they will be hostingCOVID-19 Celebrity Challenge – Survive & Thrive: Together in Isolation, presented by CBDMEDIC™ to benefit the Arthritis Foundation, on Facebook Live.

Continue readingSurvive & Thrive: Together in Isolation

Meet Dr. Laura Cannon: One of Our Newest Foundation Sponsored Fellows

Because access to care is not always guaranteed, we’ve been working to help close the gap on the nation’s rheumatologist shortage through ourfellowship initiative. As one of the five new 2020 fellowship grant awardees, Duke University announced their fellowship has been awarded to Dr. Laura Cannon.

Continue readingMeet Dr. Laura Cannon: One of Our Newest Foundation Sponsored Fellows